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The esophagus, a straight tube that connects the pharynx to the stomach, has the 
complex architecture common to the rest of the gastrointestinal tract with special 
differences that relate to its function as a conduit of ingested substances. For 
instance, it has submucosal glands that are unique that have a specific protective 
function. It has a squamous lining that exists nowhere else in the gut except the anus 
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intestines. All of the layers of the esophageal wall and the specialized structures 
including blood and lymphatic vessels and nerves have specific responses to injury. 
The esophagus also has unique features such as patches of gastric mucosa called 
inlet patches at the very proximal part and it has a special sphincter mechanism at 
the most distal aspect. This review covers the normal microscopic anatomy of the 
esophagus and the patterns of reaction to stress and injury of each layer and each 
special structure. 
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The esophagus is a straight tube connecting the mouth to the stomach. It has the 
same layers found in the rest of the gastrointestinal tract, with the mucosa on the 
inside and the muscularis propria on the outside, blood and lymphatic vessels and 
nerves, yet it has a unique job and it also has a unique set of diseases. This review 
analyzes the published information on all these layers and structures, concentrating 
on their normal microscopic anatomy and common reactions to injury. In addition, 
there is detailed analysis of two unique esophageal strictures, the inlet patch and the 
lower esophageal sphincter. 
 
How does the esophagus evolve into the normal human adult structure? 
 
The esophagus is a 23–25-cm musculomembranous tube that begins at the cricoid 
cartilage, passes through the thorax within the posterior mediastinum, and extends 
several centimeters below the diaphragm to the gastroesophageal junction (GEJ). In 
practice, clinicians use the incisor teeth as a landmark: the endoscopic distance from 
the incisor teeth to the GEJ is approximately 40 cm in adults, but it may vary from 30 
to 43 cm. The normal esophageal mucosa is lined by stratified nonkeratinized 
squamous mucosa. The lamina propria is composed of loose connective tissue that 
contains mucous glands in the distal portion. The esophageal muscularis mucosae is 
composed of longitudinally organized smooth muscle. The submucosa consists of 
irregular connective tissue that contains the larger vascular and lymphatic vessels, 
nerve fibers, and mucous glands with their ducts open into the esophageal lumen. 
The muscularis propria is composed of striated muscle in the upper part, smooth 
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plexus (Auerbach’s plexus) is present between the muscle layers. The esophagus 
lacks a serosal layer, except for its most distal portion.  
 
The primary function of the esophagus is to serve as a passage for food and liquid 
from the pharynx to the stomach. Although this process sounds straightforward, it is 
fraught with multiple barriers to its success. As described above, the esophagus is 
ensheathed by layers of muscles that are essential to generate peristalsis to move 
food. The thick stratified squamous epithelium of the mucosa is required to sustain 
the passing of the abrasive raw food, which is facilitated by secretions of the 
esophageal submucosal glands. However, the embryonic esophagus is initially lined 
with a simple columnar epithelial layer instead of stratified squamous. The human 
esophagus begins to form during the 4th week of embryonic development with the 
formation of the foregut, a structure that also gives rise to other organs including the 
trachea, lung, and stomach. Separation of the esophagus from the tracheal tube and 
transition of epithelial lining from columnar to squamous epithelium are the two major 
developmental processes. During embryonic development, the esophagus and 
trachea initially share a single-lumen tube at the anterior region of the foregut. 
Lateral grooves invaginate on each side of the proximal foregut and fuse creating the 
tracheoesophageal septum. The septum separates the tracheal tube and esophagus 
and generates the trachea ventrally and the esophagus dorsally. This tracheal-
esophageal separation occurs at approximately 4–6 weeks of gestation in humans1. 
The failure of this process results in various anomalies such as esophageal atresia 
with or without tracheoesophageal fistula (EA/TEF).  
 
It is well recognized that the separation of the esophagus from the tracheal tube is 
regulated by diverse signaling crosstalk between the epithelial cells and surrounding 
mesenchyme, which are highly coordinated by transcriptional factors and signaling 
pathways.2,3 Specifically, the dorsal foregut endoderm expressing Sox2 gives rise to 
the esophagus, while the ventral foregut endoderm expressing the transcription 
factor Nkx2.1 forms the trachea. Reciprocal inhibition occurs between Sox2 and 
Nkx2.1. Both Sox2 and Nkx2.1 are crucial factors involved in foregut separation and 
columnar to squamous epithelium transition. Nkx2.1 null mice exhibit incomplete 
foregut separation, resulting in a condition similar to tracheal agenesis, known as 
complete tracheo-esophageal cleft. Similarly, Downregulation of Sox2 in the early 
foregut leads to EA/TEF 4. The function of Sox2 and Nkx2.1 is regulated by several 
signaling pathways.1,5 WNT/β-catenin signaling pathway plays a crucial role in 
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Wnt2b are expressed in the ventral anterior mesoderm surrounding the region of the 
anterior foregut endoderm where Nkx2.1+ respiratory endoderm progenitors are 
located. Embryos lacking Wnt2/2b expression exhibit complete lung agenesis and do 
not express Nkx2.1. This phenotype is recapitulated by an endoderm-restricted 
deletion of β-catenin. The ability of Wnt/β-catenin signaling to promote Nkx2.1+ 
respiratory endoderm progenitor fate is dependent upon other associated signaling 
pathways, such as bone morphogenetic protein (Bmp) signaling.6 Loss of Bmp 
signaling in the foregut endoderm through inactivation of the Bmp receptors 
Bmpr1a/1b leads to tracheal agenesis. Bmp signaling appears to act by repressing 
Sox2, which allows for expression of Nkx2.1 in the presumptive lung endoderm.  
 
When the esophagus is completely separated from the trachea in the 4-6 weeks of 
gestation, the esophageal epithelium appears as a pseudo-stratified columnar 
epithelium, which then becomes to ciliated near the mid-esophagus at 8 weeks of 
gestation. Starting from the 4th month of gestation, the ciliated epithelium gradually 
transits to squamous epithelium bi-directionally until a nonkeratinized stratified 
squamous epithelium is fully developed. Residual islands of columnar epithelium 
remain as inlet patches or grow down to generate submucosal mucous glands. 
Meanwhile, the mesenchymal cells surrounding the nascent esophagus proliferate 
and differentiate into muscularis mucosa and the muscularis propria, with networks 
of blood vessels and nerves running throughout. Although controversies remain 
regarding the cellular origin of striated muscle and regulation of esophageal 
muscular development, the use of genetic mouse models has revealed that multiple 
genes, transcription factors and signal pathways are involved in this process.1,7 
Specifically, the cell surface receptor Cdo is required for setting up the striated-
smooth muscle boundary. The bHLH transcription factor Myf5 is required for striated 
muscle differentiation. Homeobox transcription factors Foxp1 and Foxp2 are 
important for striated muscle development. Mutants lacking Foxp2 in a Foxp1 
heterozygous background completely lose the striated muscle. Deletion of the Wnt 
signaling receptor Fz4 also affects the formation of the striated muscle, leading to 
esophageal distension. Moreover, Pax7 mutant mice develop megaesophagus due 
to the disrupted differentiation of striated muscle and abnormal orientation of smooth 
muscles8. Similar to the process of esophageal separation and muscular 
development, many transcriptional factors and signaling pathways are involved in the 
process of esophageal columnar to squamous epithelium transition. Opposite to the 
tracheal and lung development, Sox2 remains highly expressed and is required for 
the stratification and lineage differentiation of the esophageal epithelial cells. 
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Transcription factor p63, a member of the p53 family, is a potent regulator of the 
conversion of columnar into stratified squamous epithelium in the esophagus. The 
esophageal epithelium fails to stratify and remains simple columnar epithelium in p63 
mutants. During tracheal separation, the negative regulation of Bmp signaling 
causes persistent activation of Sox2 with repression of Nkx2.1, resulting in 
squamous differentiation of basal progenitor cells and eventually complete columnar 
to squamous epithelium transition. The transition of columnar to squamous 
epithelium may also represent a process of metaplasia. Interestingly, Barrett’s 
esophagus, a reverse metaplasia of the squamous epithelium lining the distal 
esophagus into an intestinalized columnar epithelium, can occur secondarily to long-
term inflammation and injury caused by gastroesophageal reflux. The molecular 
mechanisms underlying this reversed metaplasia and the cell origin are still under 
investigation. Treatment with acidified media and/or bile salts in vitro mimicking 
gastroesophageal reflux or using bile acid reflux mouse models have demonstrated 
that down-regulation of squamous transcription factors (e.g., p63 and Sox2), up-
regulation of columnar (e.g., Sox9), intestinal (e.g., Cdx1 and Cdx2) and mucin (e.g., 
Foxa2) associated transcription factors, as well as alterations in various signaling 
pathways that are involved in the development of Barrett’s esophagus.9-11 
 
In summary, the development of esophagus is a dynamic process. The two major 
processes, separation of the anterior foregut into the trachea and esophagus and 
subsequent development of the esophagus, involve reciprocal interactions between 
the epithelium and the mesenchyme that are mediated by complexed signaling 
pathways and transcription factors. Identifying and understanding the underlying 
molecular mechanisms of esophageal development, conversion of simple columnar 
into stratified squamous epithelium and reversion of stratified squamous epithelium 
back to columnar epithelium will promote greater insights into the pathophysiology of 
esophageal diseases. 
 
The squamous epithelium: why do we have a squamous lining in our 
esophagus? 
 
The word esophagus is derived from the ancient Greek words ―oisein‖ which means 
―to carry‖, and ―phagein‖, which means ―to eat‖. The function of the esophagus is 
simply to carry food into the stomach. It has no known metabolic, endocrine or 
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withstand a reasonable degree of mechanical and/or chemical trauma. A simple 
stratified non-keratinizing squamous epithelium serves this purpose by providing an 
excellent protective barrier against the partially modified food stream. The three 
layers of squamous epithelium have slightly different functions: the stratum corneum, 
also known as the functional layer, is the most superficial layer that is 4-5 cell layer 
thick. It is impervious to any luminal contents. Stratum spinosum beneath the 
corneum, on the contrary, has very prominent desmosomes, and allows active 
transportation of molecules across the cell junctions. The stratum basalis, also 
known as the basal layer, is 2-3 cell layer thick. It is the proliferative zone of the 
epithelium and compensates for the high turnover of superficial epithelial cells 
following injury.12 Interspersed within the squamous epithelium, primarily in the basal 
layer are melanocytes and Merkel cells. 
 
Is there a common set of reactions to injury to the squamous epithelium that 
occur as a result of several different stimuli? If so, what do these stimuli have 
in common? 
 
Regardless of the nature of the stimulus, squamous epithelial injury manifests in a 
finite set of responses. In fact, a multitude of stimuli can manifest with similar 
patterns of injury. These can be broadly categorized into inflammatory, pauci-
inflammatory, cytologic changes, and proliferative/regenerative changes.  
 
Inflammatory response 
Recruitment of inflammatory cells is often the initial manifestation of injury. In most 
instances, certain types of stimuli result in a predominantly neutrophil-rich, 
predominantly eosinophil-rich or predominantly lymphocyte-rich response. For 
example, erosive gastroesophageal reflux disease (GERD), infections (especially 
Candida spp. and Herpes simplex virus), and pill esophagitis are associated with 
marked neutrophilic epithelial injury, erosion and ulcer formation.13  Eosinophilic 
esophagitis, GERD, parasitic infections, Crohn’s disease, drug hypersensitivity, 
hypereosinophilic syndrome, celiac disease, vasculitis, and collagen vascular 
disorders are commonly associated with increased intraepithelial eosinophils.14 
Lymphocytes tend to be a predominant component of inflammatory cells in chronic 
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achalasia/motility disorders, autoimmune diseases, immunodeficiency (HIV/CVID), 




In some conditions, such as causative or corrosive injury, the esophageal epithelium 
undergoes extensive necrosis following direct exposure to acids or alkaline agents. 
There is very little time for the epithelium to illicit an inflammatory response. 
Similarly, esophagitis dissecans superficialis or ―sloughing esophagitis‖ is believed to 
be a manifestation of direct mucosal contact with various types of stimuli, such as 
drugs/medications (especially bisphosphonates, NSAIDs), hot beverages, and 
chemical irritants.16,17 Graft versus host disease and CVID are examples of immune-
mediated injury where the squamous epithelium shows minimal changes of 




Dilatation of intercellular spaces (DIS) or spongiosis almost always accompanies 
most forms of epithelial injury. Given that this finding has been observed in up to 
30% of asymptomatic patients, and in response to several stimuli such as erosive 
GERD, non-erosive GERD, bile acids, and stress, it has limited specificity.18 
Although the molecular mechanisms of DIS are not entirely clear, based on the 
impedance and ultrastructural studies, it appears that the degree of DIS is directly 
proportional to the diminished transepithelial resistance and increased esophageal 
mucosal permeability.19 
 
A less common manifestation of epithelial injury is ballooning change. The 
squamous epithelial cells appear pale and filled with eosinophilic fluid. This fluid 
represents plasma proteins that have accumulated within the cytoplasm of the 
epithelial cells following cellular injury.   
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Basal cell hyperplasia and regenerative epithelial changes occur concurrently with 
most aforementioned forms of injury. In some cases, epithelial injury results in 
papillomatosis, hyperkeratosis and parakeratosis. 
 
Basal cell hyperplasia is characterized by expansion of the basal proliferative zone, 
papillary height elongation, and increased mitotic activity (typically restricted to the 
basal cells) It imparts a hyperchromatic appearance to the squamous epithelium.20 In 
some patients with chronic reflux disease and eosinophilic esophagitis, the mucosa 
may show basal cell hyperplasia and marked papillary hyperplasia consistent with 
papillomatosis.    
 
Esophageal hyperkeratosis is condition where the squamous epithelium shows a 
distinct granular layer and overlying acellular keratin. In a prospective analysis of 
1845 esophageal biopsies, Taggart et al documented the prevalence rate of 
hyperkeratosis as 2%.21 In their cohort consisting of 98 patients, hyperkeratosis was 
found in two clinical settings: 1) patients with Barrett’s esophagus (BE) and BE-
associated adenocarcinoma and 2) those without BE. There was no clinical 
significance to the finding of hyperkeratosis when it was associated with BE. In 
contrast, non-BE patients with hyperkeratosis showed multifocal involvement with a 
predilection to involve the mid esophageal region. These patients were either current 
or former alcohol users. More importantly, the non-BE patients showed a high 
frequency of concurrent or prior history of esophageal squamous neoplasia (67%) or 
head and neck squamous lesions (31%). In contrast to hyperkeratosis, parakeratotic 
squamous epithelium shows epithelial hyperplasia with retention of the nuclei within 
the stratum corneum layer. There appears to be no clinical significance to this 
finding. 
 
What do these stimuli have in common? Based on our current understanding of the 
pathogenesis of epithelial injury, it appears that stimuli that result in recruitment of 
inflammatory cells (neutrophils, eosinophils or lymphocytes) share a common 
cytokine-mediated pathway of pathogenesis. A detailed discussion of the 
pathogenesis is beyond the scope of this review. Regardless of whether the stimuli 
are acid, bile salts or pancreatic enzymes that lead to recruitment of neutrophils,22,23 
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susceptible individuals,24 or the stimulus arises from an immunologic response to an 
ingested agent that causes lymphocyte recruitment, it appears that all of these 
stimuli in some way or form compromise the mucosal integrity and cause high 
transepithelial permeability.25,26 This results in release of cytokines and growth 
factors that ultimately leads to recruitment of inflammatory cells, dilatation of 
intercellular spaces and basal cell hyperplasia.  
 
In summary, the human esophagus is lined by stratified squamous epithelium to 
serve as a protective barrier from potentially harmful luminal agents. When exposed 
to an injurious agent/stimulus, the most common reactions to injury include 
recruitment of inflammatory cells, dilatation of intercellular spaces, and a rapid 
attempt to regenerate the injured squamous epithelium, which manifests as basal 
cell hyperplasia. All of these reactions can result from multiple different types of 
stimuli; however, they appear to share a common pathway of cytokine-mediated 
injury. 
 
The lamina propria and muscularis mucosae  
 
The normal lamina propria (LP) contains loose collagen, blood vessels, lymphatic 
channels and lymphocytes. In contrast to normal squamous-lined mucosa in which 
the LP forms a distinct and compact layer, in esophagi with Barrett’s esophagus 
(BE), the LP contains glandular epithelium similar to the other columnar-lined 
segments of the GI tract. The most striking changes in the LP are related to the 
muscularis mucosae (MM), which in patients with BE, undergoes duplication, 
fragmentation and expansion. This review will discuss the characteristics and 
prevalence rate of MM alterations, it’s pathogenesis, histologic properties, and 
finally, the clinical implications of this phenomenon.  
 
Muscularis mucosae alterations 
 
The original description of MM alterations in BE was by Rubio et al in 1988. In an 
evaluation of 32 esophageal resections performed for BE-associated 
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muscle fibers into the LP in 26 of 32 (81%) cases.27 However, the first study to 
describe duplication of the MM in BE was by Takubo et al. Esophagectomies from 8 
patients with BE were compared to 352 esophagectomies from patients without BE. 
Duplication of the MM was observed in 87% of BE patients, but in none of the 
controls. 28 This study showed that in BE, a new layer of MM develops more 
superficial (luminal) to the original (deep) layer of MM native to the squamous-lined 
esophagus. The superficial (newly developed) and deep layers of MM ultimately 
converge into one layer at the neo squamo-columnar junction, but distally at the level 
of the distal gastroesophageal junction, the superficial layer becomes attenuated and 
is replaced by fibrous tissue. A study by Abraham et al. showed similar findings.29 In 
that study, 46 of 50 (92%) BE resections demonstrated ―duplicated‖ MM, which 
involved between 5% to > 90% of the BE segment. However, in that study, none of 
the 20 resected squamous cell carcinomas showed changes in the MM. 
Interestingly, in 5 (10%) cases, the MM was focally divided into three distinct layers. 
In a subsequent study by Lewis et al, the authors analyzed the MM in endoscopic 
mucosal resection (EMR) specimens and found that MM duplication was present in 
73 of 111 (66%) EMR specimens.30  
 
Given that duplication of the MM in BE is a common phenomenon, its implications 
with regard to staging carcinomas, and the risk of metastasis, are of prime 
importance. For instance, one important question is whether carcinomas that 
infiltrate into, or through, the newly developed (superficial) MM behave similarly to 
true submucosally invasive cancers, or do they behave more similar to 
―intramucosal‖ cancers. Hahn et al. evaluated the vascular and lymphatic properties 
of the mucosa and submucosa in BE patients with a duplicated MM in an effort to 
determine the potential impact of this phenomenon on staging superficial 
carcinomas.31 In a cohort of esophagogastrectomy specimens from 30 patients with 
BE-associated adenocarcinoma (n = 6), intramucosal adenocarcinoma (n = 26) or 
high-grade dysplasia (n = 2), the density of CD31+ blood and lymphatic vessels in 
the superficial (n = 37) and deep LP (n = 38) was found to be significantly lower 
compared to the LP of normal squamous-lined esophagus (n = 68). However, the 
total number of blood and lymphatic vessels in the combined layers was statistically 
similar to the LP of squamous-lined esophagus. The density of CD31+ blood and 
lymphatic vessels in the submucosa of BE was not significantly different from the 
submucosa of squamous-lined esophagus. These findings suggested that 
carcinomas that invade through the superficial MM into the deep LP may behave 
biologically similar to ―intramucosal‖ (IMC), rather than ―submucosal‖ cancers, with 
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Implications for staging early adenocarcinomas in BE 
 
The presence of a duplicated MM in BE has led to challenges with regards to staging 
superficially invasive cancers. Currently, the American Joint Commission on 
Cancer/Union for International Cancer Control classifies neoplastic glands that 
invade into the superficial LP, deep LP (space between superficial and deep of MM) 
and the deep MM as pT1a.32 Invasion beyond the deep MM and into the true 
submucosa is categorized as pT1b. In fact, the risk of lymph node (LN) metastasis 
has been shown to correlate with depth of invasion. In a series of 272 endoscopic 
resections, Vieth et al classified depth of invasion into 4 levels: m1–invasion into 
superficial LP, m2–invasion into superficial (newly formed) MM, m3–invasion into the 
space between the two layers of MM, and m4–invasion into deep MM. This study 
showed that the incidence of lymphatic invasion is very low in adenocarcinomas that 
invade the m1 (0.8%), m2 or m3 (0%) levels, and progressively increases in cancers 
with level m4 (2.8%) and submucosal invasion (13–20%).33 Thus, intramucosal 
adenocarcinoma has a much lower risk of LN metastasis (0 – 3%) compared to 
submucosally invasive adenocarcinoma (8%–36%).33 In another study of 99 BE-
associated pT1 cancers, Estrella et al found LN metastasis in 1 (3%) patient with 
tumor that invaded into the LP/ inner MM, 0 patients with tumor that invaded the 
space between the superficial and deep LP, and 10 (33%) patients with tumor that 
invaded the true submucosa.34 
 
In summary, most patients with BE develop either a partial, or complete, duplication 
of the MM which is situated in the original LP above the original (deep) MM of the 
native squamous-lined esophagus. Although MM alterations result in the formation of 
a ―superficial‖ and ―deep‖ LP, the properties of the combined superficial and deep LP 
are similar to the original LP. The rate of LN metastasis (and recurrence) in 
superficially invasive adenocarcinomas that infiltrate into the superficial or deep LP is 
similar, but significantly different compared to adenocarcinomas with true 
submucosal invasion. Therefore, it is important to recognize appropriate histologic 
landmarks and distinguish ―mucosal‖ from true ―submucosal‖ invasion when staging 
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The submucosa of the esophagus provides a flexible matrix, which serves as a cushion 
between mucosa and muscularis propria during peristalsis. It is also the regional routing 
center for blood and lymphatic flows.  Histologically, the submucosa is made of loosely 
arranged collagen, elastic fibers and adipose tissue with embedded relatively large caliber 
arterioles, venules and lymphatic vessels. Neural structures and variable amount of 
scattered inflammatory cells are also components of the submucosa.   
 
A unique structure in the esophageal submucosa is the submucosal mucus gland. These are 
thought to be invagination of the surface epithelium during embryonic development or 
continuation of the minor salivary glands of the oropharynx. The presence of submucosal 
glands or their ducts in biopsies is indicative of an esophageal location, which may facilitate 
a diagnosis of Barrett’s esophagus by confirming the esophageal origin of the sampled 
specialized columnar epithelium35.   
 
A rich lymphatic network is present in the lamina propria and is further concentrated 
in the submucosa.  Several studies had suggested that lymphatics within the 
submucosa drains longitudinally along the submucosal plexuses up to its proximal 
ends (recurrent laryngeal nodes/ supraclavicular node) or down to its distal ends 
(paracardial nodes/ celiac nodes),36 bypassing the network in muscularis 
propria/adventitia and regional lymph nodes. Direct drainage into the thoracic duct 
has also been documented in autopsy studies.37,38  The exact drainage pathways 
may be highly variable among individuals39-41 and may explain "skip metastasis" as 
reported in some patients with thoracic esophageal carcinoma.  
 
While there is no anatomic landmark to divide the layers within the submucosa, 
increasing clinical interest in excising carcinomas with superficial submucosal 
invasion using endoscopic approach42 demands a unified method of documenting 
the depth of cancer invasion.  The commonly used methods, the Pragmatic 
classification (subdivision of the submucosa into three equal layers) and the Paris 
Classification for stomach (submucosal invasion ≤ 500 µm as sm1, 500-1000 µm as 
sm2 and > 1000 µm as sm3),43,44 both suffer from inconsistency created by observer 
subjectivity and processing artifact.  While most of the studies on tumor depth and 
risk of lymph node metastasis used surgical resection specimens and the pragmatic 
approach, due to incompleteness of submucosal layer in endoscopic resection 
specimens, the Paris classification may become the only solution. As a crucial 
buffering layer between the mucosa and the more rigid muscularis propria, the 
submucosal response after mucosal injury plays an important role in stricture 
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models, starting from the 2nd day after a procedure, prominent inflammatory 
infiltrates are seen in the submucosa with a significant neutrophilic component.  In 
the next two weeks, inflammation decreases and angiogenesis increases. By around 
28 days after the procedure, in addition to dense fibrosis in the submucosa, the 
muscle layer also shows significant atrophy and fibrosis, which further reduces 
contractibility and flexibility of the esophageal wall.47,48  
 
The muscularis propria  
 
The esophageal muscularis propria, through most of its length, like that in the rest of 
the gut, has two layers, an inner layer of circular smooth muscle and an outer layer 
of longitudinal muscle. In general, the inner layer is thicker than the outer. Between 
these layers it the myenteric nerve plexus. In the upper third, there is a mixture of 
skeletal and smooth muscle, with gradual loss of the skeletal muscle as the thoracic 
part of the esophagus is reached. 
 
Are there specific diseases that target the muscularis propria? 
 
Atrophy and fibrosis of the muscularis propria was found in 94% of autopsies of 
patients diagnosed with scleroderma during life. Atrophy of the circular layer of the is 
dramatically more severe than that of the longitudinal layer. 
 
Achalasia is associated with inflammation of the myenteric plexus of the m. propria.  
End-stage achalasia is characterized by the absence of ganglion cells and fibrosis of 
the nerves of the myenteric plexus.  Prominent hypertrophy of the circular layer of 
the m. propria is also characteristic. 
 
Leiomyoma constitutes approximately 60–70% of all esophageal mesenchymal 
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Gastrointestinal stromal tumors (GIST) of the esophagus constitutes less than 1% of 
all GISTs.  Esophageal GISTs are overwhelmingly C-KIT-positive by 
immunohistochemistry. They are also more aggressive than gastric GISTs. The 
criteria used for the assessment of the risk of malignant behavior are the same as for 
the jejunum/ileum GISTs. 
 
How can we distinguish between duplicated muscularis mucosae and muscularis 
propria in endoscopic mucosal resections? 
 
The term ―duplicated muscularis mucosae‖ (MM) refers to two layers of MM 
separated by connective tissue, a distinctive and common feature of Barrett’s 
esophagus (BE). The more superficial (luminal) layer of MM delimits Barrett’s 
mucosa. The deep MM is contiguous with the original MM of the squamous 
esophagus and continues caudally merging with the MM of the stomach (Fig. 1A). 
The lamina propria of the squamous esophagus is contiguous with the space 
between the duplicated MM. Below the deep MM is the submucosa. Invasion of 
adenocarcinoma into the duplicated MM space is interpreted as intramucosal 
carcinoma. Because of its patchiness, duplicated MM is seen only in a half to two 
thirds of the endoscopic mucosal resection (EMR) specimens.   
 
It may be difficult to decide in the EMR sections whether adenocarcinoma invading 
beyond the only layer of MM is intramucosal or submucosal. When a second muscle 
layer is present at the deep margin, it may be challenging to differentiate the deep 
MM from the muscularis propria (MP). Yet, the distinction is important, as invasion 
into the duplicated MM space can be treated endoscopically, while submucosal 
invasion is treated with esophagectomy. In addition, presence of MP is a worrisome 




Recognition of the submucosa will allow distinction between the deep MM and the 
MP, because it is positioned underneath the deep MM and above the MP. Distinctive 
features of the submucosa are salivary-type glands, the adipose tissue and large-
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more tortuous and clustered than the vessels in the superficial lamina propria or the 
duplicated MM space. Using the presence of the salivary-type glands, the adipose 
tissue and large-caliber muscular vessels, Kaye et al. have recently demonstrated an 
excellent agreement in recognition of the submucosa in the EMR specimens, with 
kappa values in between 0.69 and 0.96.49  
  
The nerve supply of the esophagus 
 
The esophagus receives predominantly parasympathetic nerve supply from the 
vagus, and sympathetic nerve fibers form the cervical and paravertebral chains.50 
The intrinsic nerve supply is composed of two nerve plexuses (ganglia, axons, nerve 
fibers): Auerbach’s myenteric plexus and Meissner’s submucosal plexus.  Meissner’s 
submucosal plexus has a 1) a superficial component, close to the muscularis 
mucosae, 2) Henle’s plexus – the deep component adjacent to the circular layer of 
muscularis propria, and 3) a less well defined intermediate plexus.50     
 
The history of nomenclature of the enteric plexuses includes these details.51 Henle in 
1871 described the plexus myentericus externus (between the longitudinal and 
circular muscle layer) and plexus myentericus internus (on the outer surface of the 
muscularis mucosae). The plexus myentericus externus of Henle corresponds to the 
myenteric not to the submucosal plexus. The Russian histologist Schabadash was 
the first to describe two different submucosal plexus types, an outer and an inner 
one.  However, because he misunderstood Henle's text, he called the outer 
submucosal plexus (close to the surface of the circular muscle) and the inner 
submucosal plexus: "plexus externus Henle" and "plexus internus submucosus 
Meissner" respectively. 
 
The interstitial cells of Cajal (ICCs) are present in the submucosa, intermuscular and 
intramuscular layers of the esophageal wall.50   ICCs are present in the mid 
esophagus associated with smooth and striated muscle and in the distal esophagus 
associated with smooth muscle. 52 ICCs are concentrated in the smooth muscle of 
the esophagus and within the lower esophageal sphincter. Unlike in the small and 
large bowel, ICCs do not aggregate around the myenteric plexus or at the 
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in gut motility and serve as pace makers of motility. Frequent gap junctions between 
the ICC are described in ultrastructural studies and form a network throughout the 
bowel wall. ICCs are present in close apposition to nerve varicosities and are richly 
innervated by the local nerve fibers.55 Evidence for the role of ICCs in gut motility 
and internal pace making activity has accumulated since their discovery.56-58 The 
pacemaker activity is most concentrated in the ICCs in small intestine and stomach. 
59,60 ICC within the esophageal muscle layers show little evidence of the slow 
depolarization wave production characteristic of pacemaker cells; thus not all ICCs 
are involved in pace making activities. 
 
When ICCs are absent61,62 or knocked out in a mouse model,63 pacemaker activity is 
lost. It appears diseases in which ICCs are implicated relate to decreased number of 
ICCs and developmental delay.  It remains unclear whether these abnormalities 
represent primary or secondary events affecting the ICCs. 
 
Classification of neuromuscular pathology of the GI tract can be challenging due to 
the large number of entities involved, potential overlap, and the multiple ways in 
which they can be catalogued.  The London Classification offers a structured 
classification of histologic phenotypes based on robust contemporary histopathologic 
criteria with correlation between histopathological phenotypes and entities in clinical 
practice.64  
 
The vascular and lymphatic supply of the esophagus:  
Why are there so many lymphatics in the lamina propria when no absorption 
occurs?  
 
This lymphatic supply within the esophagus begins in the lamina propria and travels 
in the lamina propria and submucosa until large r lymphatics terminate either directly 
in the thoracic duct, especially from the right and dorsal sides of the esophagus, or, 
in the remaining esophagus often being relayed through lymph nodes.  The larger 
lymphatics penetrate the wall of the esophagus and each of these may drain up to 
about 40mm of esophageal submucosa.65 The vagaries of drainage can be seen by 
studying the sites of nodal metastases from small carcinomas and the sites to which 
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many lymphatics in the esophagus, especially when it is assumed there is no 
absorption. However, we do not actually know that; absorption can certainly occur 
through the skin and squamous mucosa of the mouth so there is no reason why a 
small degree of absorption should not take place in the esophagus, albeit being 
limited by contact time.  
 
The three main areas containing lymphatics are in the lamina propria (lp) including 
the muscularis mucosae (mm), the submucosa (sm) between the mm and 
muscularis propria (mp) those in the adventitia and beyond. The corollary is whether 
the density of lymphatics is the same throughout the esophagus and whether there is 
any change with age, and therefore growth. Defining the lamina in intrauterine life is 
problematic as there is no mm in the upper part of the esophagus, so that the lp and 
sm are in continuity, and even in adults this remains thin, but is present. Further, 
using both CD31 and D240 immunohistochemistry, there appears to be an increase 
in the density of lymphatics from proximal to distal in both intrauterine life and in 
adults.  
 
Are there any diseases that lead to vascular and lymphatic alterations? Does 
ischemic injury occur in the esophagus?  
 
Congenital lymphangiectasia is incredibly rare67 and Milroy’s disease (congenital 
lymphangiectasia) is not described as affecting the esophagus. Dilated lymphatic s 
can be seen in patients with carcinomas obstructing lymphatics.  However, a variety 
of vascular disease can affect the esophagus, by far the most significant clinically 
are esophageal varices in patient with portal hypertension. These vascular or 
vascular-like diseases include the following:  
 Acute esophageal necrosis (Gurvits syndrome, black esophagus, acute necrotizing 
esophagitis, esophageal infarction) Vascular/hypoperfusion: Shock, atheroma, 
vasoconstricting agents (cocaine), necrotizing arteritis   
 Chemical injury: corrosives, acid, alcohol, medications 
 Metabolic abnormalities: hyperglycemia, uremia, sepsis, lactic acidosis, anemia, 
hypoxia, hypoproteinosis 
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 Mechanical injury, mostly iatrogenic: surgical manipulation, trauma from nasogastric 
tubes 
 Co-morbidities: peptic ulcers, renal insufficiency, coronary artery disease/congestive 
heart disease, /CHF, cirrhosis / metabolic syndrome, pulmonary disease, immune 
compromise diseases 
 
The inlet patch 
 
The ―inlet patch‖ refers to a discrete focus (or foci) of gastric-type mucosa in the 
cervical esophagus.  The term was coined by Jabbari and colleagues in their 1985 
prospective endoscopy study, which encompasses most of its key clinicopathologic 
features.68 The inlet patch had been referred to previously as ectopic or heterotopic 
gastric mucosa of the upper (proximal, cervical) esophagus, mainly in the setting of 
case reports of symptomatic patients.  Jabbari et al found an endoscopic prevalence 
of 3.8% (8M:8W) in 420 consecutive upper endoscopies.  All lesions were located ≤ 
3 cm from the upper esophageal sphincter, ranged in size from 2 mm to 
circumferential, and were single (88%) or paired (12%).  One patient, who happened 
to have the largest inlet patch in the series, had throat discomfort, which was 
relieved by an H2 blocker.  Endoscopic mucosal biopsy material demonstrated 
corpus or cardia-type mucosa; no patient had intestinal metaplasia of the inlet patch.  
Inlet patches produced acid on pentagastrin stimulation.  One patient (6.3%) had 
concurrent Barrett’s esophagus. This brief summary will discuss the origin, 
prevalence, and clinical significance of the inlet patch. 
 
Inlet patches appear to represent developmental residua—a conclusion based on 
detailed morphologic analysis of human embryos and its frequent detection in 
pediatric patients (the greatest reported inlet patch prevalence is from a pediatric 
autopsy study).  The earliest recognizable esophageal lining is a stratified columnar 
epithelium (i.e., at the 3 mm crown rump-length stage).69  Perhaps inlet patches are 
residuals of this columnar lining that have undergone maturation to gastric mucosae. 
 
The reported prevalence of the inlet patch (0.1 to 21%)70,71 has varied widely 
depending on who looks, how they look, and how hard they look and does not 
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prospective endoscopy study, Peitz and colleagues reported a prevalence of 14.5% 
(54/372); when this same group looked back at nearly 10,000 of their prior upper 
endoscopies, it had been documented in only 0.5%.72  A few prospective studies 
have compared the prevalence in the operator aware (i.e., endoscopist with 
knowledge that the purpose of the study is to determine inlet patch prevalence) 
versus operator unaware settings, with the prevalence typically 6 times higher in the 
former.73  In some studies narrow band imaging or high-definition white light 
endoscopy have been shown to increase the detection rate.  The vast majority of 
studies have recruited patients presenting for upper endoscopy, though Govani and 
colleagues reported a prevalence of 6.9% in volunteers.74  
 
Although most patients do not have symptoms referable to their inlet patch, the most 
frequently attributed are laryngopharyngeal, including globus, cough, and 
laryngospasm.  Rarely, large inlet patches have been reported to causes strictures, 
rings, webs, bleeding, ulceration, or perforation.  In patients with attributable 
symptoms, inlet patches can be endoscopically ablated.75 Helicobacter is variably 
detected in the inlet patches of patients in whom the stomach is infected.  A half 
dozen studies have reported a positive association between the presence of an inlet 
patch and concurrent Barrett’s esophagus, but just as many studies have failed to 
demonstrate an association.  It is possible that endoscopists may have looked 
harder (even subconsciously) for inlet patches in the setting Barrett’s.  Intestinal 
metaplasia is uncommonly seen in biopsy material from inlet patches (3% of 2000 
cases across a couple dozen studies), and upper esophageal adenocarcinoma, 
possibly arising in inlet patches, is exceptional, with only 58 previously reported 
cases.  As such, inlet patches do not routinely need to be biopsied because of the 
possibility of dysplasia or carcinoma.76        
 
The submucosal glands and their ducts, and the cardiac glands 
 
Function and microanatomy of submucosal glands and ducts 
 
Submucosal glands and ducts play an important role in maintaining the 
seromucinous pre-epithelial barrier of the squamous mucosa.77 They secrete 
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factor (EGF), transforming growth factor-alpha (TGF-alpha), and prostaglandin E2 
(PGE2) to maintain the integrity of the squamous mucosa.78  Submucosal glands 
also secrete a variety of defensive cell products; neutral and sialated mucins prevent 
viruses and bacteria from infiltrating the underlying mucosa, lysozymes are 
bactericidal, and pepsinogen is activated to pepsin, which contributes to proteolysis. 
 
Submucosal glands and their ducts are arranged in rows parallel to the long axis of 
the esophagus. Aggregates of 2–5 lobules drain into a common duct that penetrates 
the squamous epithelium and extends to the surface. These ducts contain two cell 
layers.  An inner layer of short columnar epithelial cells is supported by an outer 
layer of smaller cuboidal cells; both are surrounded by a cuff of lymphocyte-rich 
mononuclear cell inflammation.  As the ducts extend to the luminal surface, the 
flattened cuboidal epithelium gradually transitions to a stratified squamous epithelium 
subjacent to short columnar cells that line the duct lumen.  
 
Submucosal glands are most numerous in the proximal esophagus, although their 
presence in the distal esophagus represents a helpful histologic landmark that 
defines the extent of the tubular esophagus. Submucosal glands consist of acini 
invested in a peripheral rim of myoepithelial cells; acini contain variable numbers of 
mucous cells, serous cells, and oncocytic cells. Mucous cells are more numerous 
and generally predominate in lobules at all levels in the esophagus.  They contain 
sulphomucins that impart a faintly basophilic hue to their cytoplasm and they show 
strong staining for Alcian blue.  Serous cells contain deeply basophilic, granular 
cytoplasm and peripherally arranged, small, round nuclei; they may be absent from 
some submucosal glands. Oncocytic cells are cuboidal with abundant, densely 
eosinophilic cytoplasm and uniform, round nuclei with conspicuous nucleoli.  
 
Function and microanatomy of cardiac-type glands in the esophagus 
 
Cardiac-type glands are normally present in the esophagus where they function to 
lubricate and protect the mucosa; loss of cardiac-type glands is associated with 
gastroesophageal reflux disease.79 Hanada et al. performed endoscopic 
examinations on 2656 patients in search of cardiac-type glands on the proximal side 
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355 (13%) patients. Cardiac-type glands were patchy in 9.7% patients, but appeared 
as multiple foci over < 50% and > 50% of the esophageal circumference in 1.8% and 
1.9% of patients, respectively.  Cardiac-type glands were more common among 
women and their presence was inversely associated with gastroesophageal reflux 
disease80. 
 
Lobules of cardiac-type glands are commonly present in the mucosae of the 
proximal and distal esophagus, where they appear as white or yellow nodules and 
plaques80. These lobules consist of small aggregates (< 10) of glands invested in 
lamina propria that contains plasma cells and lymphocytes. Glands are lined by 
columnar to short cuboidal cells with basally located nuclei and faintly eosinophilic 
mucinous cytoplasm. These cardiac-type glands are morphologically 
indistinguishable from cardiac-type glands in the proximal stomach. 
 
Diseases of submucosal glands and their ducts, and cardiac glands 
 
Submucosal glands, ducts, and cardiac glands produce mucins and biologically 
active peptides that lubricate the esophageal mucosa and protect it from direct 
luminal injury and pathogens. Inflammatory disorders that involve these structures 
may pose problems for pathologists who encounter them in biopsy or resection 
material, but clinically significant diseases affecting these structures are uncommon.  
Radiation-induced atrophy of glands may cause diagnostic challenges for 
pathologists in some cases, although their benign nature can usually be discerned 
owing to the lobular arrangement of glandular elements, many of which show 
variable dilation and attenuated epithelium. Although radiation may induce single cell 
necrosis in benign glands, nuclear enlargement is generally accompanied by 
concomitant increases in cytoplasmic volume and an absence of mitotic activity. 
 
Intramural diverticulosis (pseudodiverticulosis) is a clinically asymptomatic disorder 
characterized by diffusely dilated submucosal glands and ducts throughout the 
esophagus.  Most cases occur in patients with underlying esophageal motility 
disorders or strictures.  Presumably, increased intraluminal pressures result in 
herniation of submucosal glands and their supportive tissue into the muscularis 
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amounts of inflammation and fibrosis, reminiscent of Rokitansky–Aschoff sinuses in 
the gallbladder. Isolated cysts derived from esophageal ducts can also occur, 
resulting in an endoscopically apparent bulge or nodule that usually spans less than 
1 cm. Cysts contain mucin and may display papillary intraluminal folds, but lack 
cytologic atypia. Most examples are encountered among patients with 
gastroesophageal reflux disease.81 
 
Glandular elements in the tubular esophagus may give rise to esophageal 
adenocarcinomas that develop in the upper and mid esophagus unrelated to 
columnar-lined esophagus. Nie et al. identified three examples of an entity they 
classified as esophageal submucosal gland duct adenoma.81 These lesions 
consisted of multiple cysts lined by flat, undulating, or slightly papillary epithelium. All 
three cases featured two layers of epithelial cells with luminal ductal cells and basal 
cuboidal cells. The proliferative indices of all three cases were < 1% and all showed 
only minimal to mild cytologic abnormalities. It is not clear whether these lesions 
represented neoplasms or exuberant hyperplasia. 
 
There are a few well-documented case reports of adenocarcinoma derived from 
submucosal glands and ducts, most of which have been reported in the Japanese 
literature. Unlike adenocarcinomas associated with Barrett esophagus and 
squamous cell carcinoma, those derived from esophageal glands seem to affect men 
and women equally and occur in older adults. Early lesions may appear as a nodule, 
ulcer, or depressed area, often occurring in the upper or mid esophagus. Most 
tumors resemble carcinomas that develop in the salivary glands with 
mucoepidermoid carcinoma being the most common variant.82 Of note, most 
historical examples of esophageal adenoid cystic carcinoma represent squamous 
cell carcinomas with prominent basaloid features, and many reported cases of 
―mucoepidermoid carcinoma‖ show high grade cytologic features that warrant 
classification as adenosquamous carcinoma. 
 
In summary, esophageal cardiac glands, submucosal glands, and their ducts are 
normally present throughout the esophagus, and are more numerous in the proximal 
and distal esophagus. Their primary function appears to be maintenance of mucosal 
integrity and lubrication of the esophageal mucosa. Although these structures may 
be subject to inflammatory or metaplastic alterations that pose diagnostic challenges 
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Esophageal adenocarcinomas may be derived from esophageal glands in some 
cases, although well documented cases of cancers derived from these structures are 
uncommon. 
 
The gastroesophageal junction and the lower esophageal sphincter 
 
The gastroesophageal junction (GEJ) has different definitions depending on the 
discipline that studies it.  Anatomic, physiologic, histologic, and endoscopic 
definitions of the GEJ exist.  
 
In healthy individuals, the GEJ is anatomically defined as the transition of the 
esophagus to the gastric cardia, which also corresponds to ―angle of His‖,83 or where 
the esophagus and stomach meet (Z line). Histologically, it is defined as the junction 
of squamous and columnar mucosa.83-85 Several different endoscopic criteria for 
defining the GEJ exist, but the most commonly used and reproducible one is the 
―proximal margin of the gastric folds‖, although ―distal end of esophageal palisading 
longitudinal vessels‖ is also being used.83,86,87  In addition, AJCC 2010 defines the 
GEJ as ―The junction of the tubular esophagus and the stomach, irrespective of the 
type of epithelial lining of the esophagus‖.88 However, all of these definitions may not 
correspond to the exact same area. Identifying the correct location of the GEJ has 
several important clinical implications, including diagnosis and endoscopic grading of 
Barrett’s esophagus,83,88,89 staging of GEJ and stomach cancers,88,90 and surgical 
classification and management of GEJ tumors.91,92   
 
From a physiologic perspective, the GEJ is generally defined as ―the manometric 
high pressure zone at the lower esophagus‖ which separates the negative pressure 
of the thoracic esophagus from the positive pressure of the stomach.93 This area 
corresponds to the lower esophageal sphincter (LES).  The LES is not a true 
anatomic sphincter and this is a topic of continuous debate.83,85,93,94  Currently it is 
believed that the LES consists of several different components, to include the gastric 
clasp muscle (located at the lesser curvature of the stomach), gastric sling muscle 
(located at the cardia), longitudinal outer smooth muscle, and the crural diaphragm 
that serves as an anti-reflux barrier.85,93,94 The phreno-esophageal ligament attaches 
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neutral position following peristalsis.85  Proper function of these structures play an 
important role in swallowing and reflux/anti-reflux mechanisms. 
 
To summarize, as can be seen from this detailed analysis, the esophageal wall, from 
mucosa through muscularis propria, is beautifully designed to fulfill its limited 
function as a conduit, bringing materials from the mouth and oropharynx to the 
stomach. Each of its layers and special structures, including blood and lymphatic 
vessels and nerves, respond to a variety of insults and injuries in remarkable ways, 
many of which have been detailed above. It is remarkable that a part of the gut, the 
esophagus, that is so short and so narrow has so many diseases intrinsic to it. 
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